The McKnight Brain Institute’s signature programs in neurological diseases include brain tumor immunotherapy and a range of neurodegenerative disorders including ALS, Alzheimer’s disease and Parkinson’s disease. The MBI is dedicated to accelerating discoveries in these fields to enhance brain health and develop innovative therapies. 1Florida Alzheimer’s Disease Research Center…
The McKnight Brain Institute’s signature programs in age-related cognitive decline, developmental disorders, sensory dysfunction, pain, and neuropsychiatric diseases including substance use disorders. The MBI is dedicated to accelerating discoveries to enhance brain health and develop innovative therapies. Center for Addiction Research & Education (CARE) CARE facilitates collaborative…
Dr. Michael Okun discusses new JAMA Parkinson’s disease review co-authored with Dr. Melissa Armstrong.
Read about how the MBI and Fixel institutes are working together to propel neuroscience and neuromedicine research at UF.
Study reveals that many psychiatric disorders arise from common genes
New UF-led study in Science Advances offers insights into the likelihood of success of adoptive cellular therapy in certain brain tumor patients
Drs. Jolie Barter and Brittney Yegla among top six poster presenters at annual MBRF event.
Drs. Matthew Farrer, Tirisham Gyang and Giridhar Kalamangalam have been named to endowed professorships.
Dr. Michael Jaffee discusses research efforts examining military risk factors for Alzheimer's disease and related dementias.
Dr. Ellen Terry is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.
